Source: BioSpace

Cesca: Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

ThermoGenesis to Focus on Developing Automated Cell Processing Tools and Services for the Cell and Gene Therapy Field

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Chris Xu's photo - Chairman & CEO of Cesca

Chairman & CEO

Chris Xu

CEO Approval Rating

77/100

Read more